Amy Brown

2.9k total citations · 2 hit papers
34 papers, 1.9k citations indexed

About

Amy Brown is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Epidemiology. According to data from OpenAlex, Amy Brown has authored 34 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Reproductive Medicine, 12 papers in Obstetrics and Gynecology and 10 papers in Epidemiology. Recurrent topics in Amy Brown's work include Endometrial and Cervical Cancer Treatments (12 papers), Ovarian cancer diagnosis and treatment (11 papers) and Cervical Cancer and HPV Research (5 papers). Amy Brown is often cited by papers focused on Endometrial and Cervical Cancer Treatments (12 papers), Ovarian cancer diagnosis and treatment (11 papers) and Cervical Cancer and HPV Research (5 papers). Amy Brown collaborates with scholars based in United States, Australia and United Kingdom. Amy Brown's co-authors include Richard G. Moore, Robert C. Bast, Michael Craig Miller, Steven J. Skates, W. Jeffrey Allard, Paul DiSilvestro, Robert J. Kurman, C.O. Granai, W Gajewski and D. Scott McMeekin and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Obstetrics and Gynecology and Nutrients.

In The Last Decade

Amy Brown

31 papers receiving 1.9k citations

Hit Papers

A novel multiple marker bioassay utilizing HE4 and CA125 ... 2007 2026 2013 2019 2008 2007 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass
    2008 641 citations Richard G. Moore, D. Scott McMeekin et al. Gynecologic Oncology profile →
  2. The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass
    2007 532 citations Richard G. Moore, Amy Brown et al. Gynecologic Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy Brown United States 13 1.4k 733 499 328 292 34 1.9k
Chiou‐Chung Yuan Taiwan 25 727 0.5× 734 1.0× 371 0.7× 367 1.1× 124 0.4× 92 1.7k
Amin Makar Belgium 21 657 0.5× 501 0.7× 376 0.8× 323 1.0× 175 0.6× 72 1.5k
Paul D. DePriest United States 28 2.4k 1.7× 1.3k 1.8× 714 1.4× 260 0.8× 266 0.9× 64 3.0k
Angela Musella Italy 23 731 0.5× 546 0.7× 327 0.7× 197 0.6× 132 0.5× 75 1.5k
Steven C. Plaxe United States 24 745 0.5× 706 1.0× 403 0.8× 294 0.9× 136 0.5× 102 1.8k
Eric L. Jenison United States 18 1.5k 1.1× 563 0.8× 591 1.2× 574 1.8× 214 0.7× 37 2.6k
Leen Verleye Belgium 14 1.7k 1.2× 902 1.2× 1.2k 2.4× 166 0.5× 120 0.4× 52 2.2k
Keng Shen China 28 1.2k 0.8× 614 0.8× 550 1.1× 1.1k 3.3× 695 2.4× 154 2.8k
Ivor Benjamin United States 22 747 0.5× 296 0.4× 274 0.5× 435 1.3× 314 1.1× 45 1.8k
Se Ik Kim South Korea 21 704 0.5× 504 0.7× 255 0.5× 504 1.5× 313 1.1× 126 1.7k

Countries citing papers authored by Amy Brown

Since Specialization
Citations

This map shows the geographic impact of Amy Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Brown more than expected).

Fields of papers citing papers by Amy Brown

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Brown. The network helps show where Amy Brown may publish in the future.

Co-authorship network of co-authors of Amy Brown

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Brown. A scholar is included among the top collaborators of Amy Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Brown. Amy Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Cameron, Adrian J., Amy Brown, Liliana Orellana, et al.. (2022). Change in the Healthiness of Foods Sold in an Australian Supermarket Chain Following Implementation of a Shelf Tag Intervention Based on the Health Star Rating System. Nutrients. 14(12). 2394–2394. 6 indexed citations
3.
Ananthapavan, Jaithri, Gary Sacks, Liliana Orellana, et al.. (2022). Cost–Benefit and Cost–Utility Analyses to Demonstrate the Potential Value-for-Money of Supermarket Shelf Tags Promoting Healthier Packaged Products in Australia. Nutrients. 14(9). 1919–1919. 4 indexed citations
4.
Blake, Miranda R., Gary Sacks, Christina Zorbas, et al.. (2021). The ‘Eat Well @ IGA’ healthy supermarket randomised controlled trial: process evaluation. International Journal of Behavioral Nutrition and Physical Activity. 18(1). 36–36. 12 indexed citations
5.
6.
Kulkarni, Aniket, Lindsey Beffa, Kerri S. Bevis, et al.. (2020). Does adjuvant treatment increase risk of midurethral sling complications after concomitant surgery for endometrial cancer and stress urinary incontinence?. Gynecologic Oncology. 159. 240–240.
7.
Angarita, Ana M., Rayna K. Matsuno, Edward J. Tanner, et al.. (2016). Unplanned 30-day hospital readmission as a quality measure in gynecologic oncology. Gynecologic Oncology. 143(3). 604–610. 25 indexed citations
8.
Hill, Emily K., Ashley Stuckey, Christina Raker, et al.. (2016). Current Mentorship Practices in Gynecologic Oncology [20P]. Obstetrics and Gynecology. 127(Supplement 1). 136S–136S. 1 indexed citations
9.
Carmen, Marcela G. del, et al.. (2014). CA 125 and Epithelial Ovarian Cancer: Role in Screening, Diagnosis, and Surveillance. 10(6). 17 indexed citations
10.
Brown, Amy, et al.. (2013). Clear cell adenocarcinoma of the uterine cervix in an 18 year-old pregnant female. PubMed. 5. 49–51. 3 indexed citations
11.
Moore, Richard G., et al.. (2011). Utility of Tumor Marker HE4 to Predict Depth of Myometrial Invasion in Endometrioid Adenocarcinoma of the Uterus. International Journal of Gynecological Cancer. 21(7). 1185–1190. 56 indexed citations
12.
Moore, Richard G., Amy Brown, Katina Robison, et al.. (2010). Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass. American Journal of Obstetrics and Gynecology. 203(3). 228.e1–228.e6. 246 indexed citations
13.
14.
Grosso, Patricia Del, et al.. (2008). Strategies for Promoting Prevention and Improving Oral Health Care Delivery in Head Start Findings from the Oral Health Initiative Evaluation. Mathematica Policy Research Reports. 3 indexed citations
15.
Moore, Richard G., Amy Brown, Michael Craig Miller, et al.. (2008). Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus. Gynecologic Oncology. 110(2). 196–201. 182 indexed citations
16.
Moore, Richard G., Katina Robison, Amy Brown, et al.. (2008). Isolated sentinel lymph node dissection with conservative management in patients with squamous cell carcinoma of the vulva: A prospective trial. Gynecologic Oncology. 109(1). 65–70. 40 indexed citations
17.
Moore, Richard G., D. Scott McMeekin, Amy Brown, et al.. (2008). A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass. Gynecologic Oncology. 112(1). 40–46. 641 indexed citations breakdown →
18.
Csipke, Emese, Robin Touquet, Jason Franklin, et al.. (2007). Use of blood alcohol concentration in resuscitation room patients. Emergency Medicine Journal. 24(8). 535–538. 13 indexed citations
19.
Brown, Amy, et al.. (2006). The prognostic significance of lower uterine segment involvement in surgically staged endometrial cancer patients with negative nodes. Gynecologic Oncology. 105(1). 55–58. 25 indexed citations
20.
Brown, Amy, et al.. (2005). Abnormal cervical cytology: a risk factor for endometrial cancer recurrence. International Journal of Gynecological Cancer. 15(3). 517–522. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chiou‐Chung Yuan Breakdown of academic impact, for papers by Amin Makar Breakdown of academic impact, for papers by Paul D. DePriest Breakdown of academic impact, for papers by Angela Musella Breakdown of academic impact, for papers by Steven C. Plaxe Breakdown of academic impact, for papers by Eric L. Jenison Breakdown of academic impact, for papers by Leen Verleye Breakdown of academic impact, for papers by Keng Shen Breakdown of academic impact, for papers by Ivor Benjamin Breakdown of academic impact, for papers by Se Ik Kim
Rankless by CCL
2026